Enrich and detect CTCs of prostate cancer from blood

Enrich and detect CTCs of prostate cancer from blood

March 01, 2017

Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. In prostate cancer, the expression of three tumor-associated transcripts, prostate-specific membrane antigen (PSMA), prostate-specific antigen (PSA) and epidermal growth factor receptor (EGFR), are often altered and used as biomarkers.

In addition, cell surface PSMA presents a unique target for treatment of patients early in their development of prostatic metastases.
How can you detect PSMA, PSA and EGFR in prostate cancer from blood? Learn more

 

 

Analysis of edible fats and oils from Metrohm!

Analysis of edible fats and oils from Metrohm!

As the determination of the exact content of individual glycerides in fats and oils is difficult and time-consuming, several fat sum parameters or fat indices are used for the characterization and quality control of fats and oils.

November 20, 2019 More +
SOMATIC 2 MASTR Plus and QC Plex Product Release

SOMATIC 2 MASTR Plus and QC Plex Product Release

Multiplicom is pleased to introduce the SOMATIC 2 MASTR™ Plus, a research use only assay, for sequencing analysis of genes involved in pathways of solid tumors formation. The SOMATIC 2 MASTR Plus is provided as a ready to use assay in three multiplex PCR reactions for the identification of mutations in the complete coding regions of the EGFR, ERBB2, PIK3CA, PIK3R1 and PTEN genes.

March 24, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us